Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial nitric oxide synthase gene therapy for erectile dysfunction.

Trinity J Bivalacqua1, Biljana Musicki, Mustafa F Usta

  • 1Department of Urology, Tulane Health Sciences Center, 1430 Tulane Avenue SL42, New Orleans, LA 70112, USA.

Current Pharmaceutical Design
|December 28, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous sacral neurostimulation of penile erection during radical prostatectomy: surgical technique.

Translational andrology and urology·2026
Same author

Periprocedural anti-thrombotic therapy and priapism recurrence after surgical shunting: a propensity-matched analysis.

The journal of sexual medicine·2026
Same author

Predicting major ischemic priapism: a novel dynamic nomogram based on recurrent ischemic priapism risk factors.

The journal of sexual medicine·2026
Same author

Changes in sexual quality of life in patients with stress urinary incontinence treated with an artificial urinary sphincter; analysis of the artificial urinary sphincter clinical outcomes trial (AUSCO).

The journal of sexual medicine·2026
Same author

Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial.

JAMA internal medicine·2026
Same author

Safety and tolerability of a novel implantable neurostimulator to improve erectile function: a pilot study in patients with spinal cord injury.

The journal of sexual medicine·2026

Erectile dysfunction (ED) is primarily a vascular disease linked to endothelial dysfunction. Restoring endothelial nitric oxide synthase (eNOS) through gene therapy may offer a new treatment for ED.

Area of Science:

  • Urology
  • Vascular Biology
  • Gene Therapy

Background:

  • Erectile dysfunction (ED) is increasingly recognized as a vascular disease.
  • Conditions like diabetes, hypercholesterolemia, and cardiovascular disease significantly increase ED incidence.
  • Endothelial dysfunction is a key factor in the development of ED.

Purpose of the Study:

  • To review the role of endothelial nitric oxide synthase (eNOS) in erectile physiology.
  • To discuss alterations in eNOS expression in penile vascular diseases.
  • To explore eNOS as a potential target for ED gene therapy.

Main Methods:

  • Review of existing scientific literature on eNOS and erectile dysfunction.
  • Analysis of the role of nitric oxide (NO) in vascular homeostasis and erectile function.

Related Experiment Videos

  • Examination of eNOS expression in various vascular pathologies of the penis.

    • Main Results:

    • ED is predominantly a vascular disease.
    • Endothelial dysfunction, involving loss of eNOS function, is integral to ED pathogenesis.
    • Altered eNOS expression is observed in various penile vascular diseases.

    Conclusions:

    • eNOS plays a critical role in maintaining erectile function.
    • Gene therapy targeting eNOS to restore endothelial function presents a promising future strategy for ED treatment.